Predictive Oncology Inc. POAI NASDAQ

Predictive Oncology Inc. (POAI) generated $-3.74M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $0.00, free cash flow was $-3.74M.

Free cash flow margin was -43130% of revenue. Cash conversion ratio was 0.02x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (28/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (10/100) — Cash conversion ratio was 0.02x suggests some earnings are non-cash items

Overall SharesGrow Score: 28/100 with 1/7 criteria passed.